These Analysts Cut Their Forecasts On Workday After Q1 Results
Workday, Inc. (NASDAQ:WDAY) posted upbeat earnings for its first quarter on Thursday. Workday reported quarterly earnings of $1.74…
Equinor And Partners Pump $1.1B Into Troll West Expansion, Fueling Europe’s Future
Equinor and Troll partners invest NOK 12B to maintain high gas production until 2030, also approved for Empire Wind 1 offshore wind farm.
What’s Going On With Alibaba Stock On Friday?
Alibaba expands global cloud computing availability, leveraging AI products for growth. Plans to build data centers in key markets. Stock down 0.5%.
Alphabet, Meta Engage Hollywood Studios in Major AI Video Licensing Deals
Hollywood studios cautious about licensing content to Alphabet, Meta, and Microsoft for AI video generation due to concerns over misuse and control.
Fear & Greed Index Moves To ‘Neutral’ Zone; Dow Records Worst Day of 2024
The CNN Money Fear and Greed index showed further decline in the overall market sentiment, with the index…
Ross Stores, Booz Allen Hamilton And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor…
Ondas Holdings And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 600 points on Thursday. When insiders purchase or sell shares,…
Bitcoin Spot ETFs Record $108M Inflows While Ethereum ETF Potential Remains Uncertain
The cryptocurrency market has witnessed notable fund movements, particularly within Bitcoin (CRYPTO: BTC) and Ethereum (CRPYPTO: ETH) ETFs, as institutional interest fluctuates and
Wall Street On Track To Rebound As Traders Train Eyes On Key Data Ahead Of Long Weekend: Analyst Says Brace For More Gains In Second-Half
Wall Street is eyeing a return to winning ways on Friday after the lackluster sentiment seen in the past two sessions. The index futures held modestly higher in early trading.
Verastem Oncology Begins FDA Submission for Accelerated Approval of New Cancer Treatment, Seeks Priority Review for Innovative Ovarian Cancer Drug Combo
Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it has initiated the rolling submission of a New Drug Application (NDA) to